s6y
Company name or ticker
Search
Raphael Pharmaceutical Inc.
DEF 14C
Definitive information statements
Filed
Tuesday, June 4, 2024
Period
Jun 4, 2024
Accession number
0001213900-24-049686
Documents
INFORMATION STATEMENT
DEF 14C
On sec.gov
Filing index
All files
Complete submission text
SGML header